As of 30 Sep 2025, 9 institutional investors reported holding 3,372,631 shares of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,372,631 | $1,091,685 | +$844,320 | $0.08 | 9 |
| 2025 Q2 | 3,148,378 | $389,343 | +$270,938 | $0.12 | 8 |
| 2025 Q1 | 913,904 | $129,017 | -$1,793 | $0.14 | 6 |
| 2024 Q4 | 926,806 | $193,117 | -$441,093 | $0.21 | 5 |
| 2024 Q3 | 3,131,813 | $625,708 | +$7,100 | $0.20 | 5 |
| 2024 Q2 | 3,096,314 | $618,935 | +$27,189 | $0.20 | 5 |
| 2024 Q1 | 2,958,733 | $538,489 | +$15,711 | $0.18 | 4 |
| 2023 Q4 | 2,956,318 | $236,269 | +$57,063 | $0.08 | 6 |
| 2023 Q3 | 2,399,469 | $120,701 | -$13,823 | $0.05 | 8 |
| 2023 Q2 | 2,451,254 | $344,547 | +$40,083 | $0.14 | 10 |
| 2023 Q1 | 129,537 | $26,000 | -$79,573 | $0.20 | 1 |
| 2022 Q4 | 526,015 | $16,000 | -$2,001 | $0.03 | 1 |
| 2022 Q3 | 1,982,503 | $134,000 | +$2,682 | $0.07 | 12 |
| 2022 Q2 | 1,921,294 | $48,128 | -$18 | $0.00 | 10 |
| 2022 Q1 | 1,954,510 | $149,403 | -$10,107 | $0.00 | 15 |
| 2021 Q4 | 2,014,163 | $827,145 | -$355,423 | $0.00 | 16 |
| 2021 Q3 | 2,491,723 | $3,670,000 | +$3,654,972 | $1.48 | 16 |